Zhe Jiang Hua Hai Pharmaceuticalco.,ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Huahai Pharmaceutical Co., Ltd. is committed to the cause of human health and is committed to providing high-quality medical and health products to patients worldwide, continuously improving product accessibility, and improving the quality of life for the general public. Huahai Pharmaceutical was founded in 1989, with its headquarters located in Zhejiang, China. The company currently has over 7000 employees and over 40 subsidiaries worldwide (including China, the United States, Japan, Germany, etc.); Our main business covers multiple fields such as chemical drugs, biopharmaceuticals, pharmaceutical packaging, and trade circulation. We have established long-term cooperative relationships with over 800 pharmaceutical companies worldwide and provide medical and health products to over 100 countries and regions. The company's products cover fields such as cardiovascular, mental disorders, nervous system, and anti infection, and is one of the world's leading manufacturers of cardiovascular and mental health medical products. As a leading enterprise in the internationalization of Chinese medicine, Huahai Pharmaceutical is the first pharmaceutical company in China to pass the FDA formulation quality certification in the United States and independently own the ANDA registration number. It is also the first Chinese pharmaceutical company to achieve large-scale formulation sales in the United States, establishing a Chinese pharmaceutical quality image in the world's high-end pharmaceutical market. At the same time, the company relies on its own international platform to operate the global market and lead China's pharmaceutical industry to break out of the country and enter the world, striving for the rise of the Chinese pharmaceutical industry. In China, Huahai preparation products have covered more than 30 provinces and cities in China. As a national pharmaceutical enterprise, Huahai Pharmaceutical is committed to providing medical and health products of international quality and domestic prices to the Chinese people, serving their health. |
| Headquarter | Taizhou |
| Establish Date | 2/28/2001 |
| Listed Code | 600521.SH |
| Listed Date | 3/4/2003 |
| Chairman | Li Hong. |
| CEO | Chen Baohua. |
| Website | www.huahaipharm.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
